Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 55

1.
2.

Balloon-Occlusion Technique for Managing Portal Vein Hemorrhage in Liver Transplantation.

Seal JB, Bohorquez H, Battula N, DeGregorio L, Bugeaud E, Bruce DS, Carmody IC, Cohen AJ, Loss GE.

Ochsner J. 2017 Spring;17(1):76-79.

3.

Antibody-Mediated Rejection: A Review.

Garces JC, Giusti S, Staffeld-Coit C, Bohorquez H, Cohen AJ, Loss GE.

Ochsner J. 2017 Spring;17(1):46-55.

4.

Novel Biliary Reconstruction Techniques During Liver Transplantation.

Carmody IC, Romano J, Bohorquez H, Bugeaud E, Bruce DS, Cohen AJ, Seal J, Reichman TW, Loss GE.

Ochsner J. 2017 Spring;17(1):42-45.

5.

Post-Liver Transplant Delirium Increases Mortality and Length of Stay.

Oliver N, Bohorquez H, Anders S, Freeman A, Fine K, Ahmed E, Bruce DS, Carmody IC, Cohen AJ, Seal J, Reichman TW, Loss GE.

Ochsner J. 2017 Spring;17(1):25-30.

6.

Safety and Outcomes in 100 Consecutive Donation After Circulatory Death Liver Transplants Using a Protocol That Includes Thrombolytic Therapy.

Bohorquez H, Seal JB, Cohen AJ, Kressel A, Bugeaud E, Bruce DS, Carmody IC, Reichman TW, Battula N, Alsaggaf M, Therapondos G, Bzowej N, Tyson G, Joshi S, Nicolau-Raducu R, Girgrah N, Loss GE.

Am J Transplant. 2017 Aug;17(8):2155-2164. doi: 10.1111/ajt.14261. Epub 2017 Apr 11.

7.

Outcomes utilizing imported liver grafts for recipients with hepatocellular carcinoma.

Battula N, Reichman TW, Amiri Y, Carmody IC, Galliano G, Seal J, Bugeaud E, Bohorquez H, Bruce D, Cohen A, Loss GE.

Liver Transpl. 2017 Mar;23(3):299-304. doi: 10.1002/lt.24709.

8.

Using on-site liver 3-D reconstruction and volumetric calculations in split liver transplantation.

Reichman TW, Fiorello B, Carmody I, Bohorquez H, Cohen A, Seal J, Bruce D, Loss GE.

Hepatobiliary Pancreat Dis Int. 2016 Dec;15(6):587-592.

PMID:
27919847
9.

Epsilon-Aminocaproic Acid Has No Association With Thromboembolic Complications, Renal Failure, or Mortality After Liver Transplantation.

Nicolau-Raducu R, Ku TC, Ganier DR, Evans BM, Koveleskie J, Daly WJ Jr, Fish B, Cohen AJ, Reichman TW, Bohorquez HE, Bruce DS, Carmody IC, Loss GE, Gitman M, Marshall T, Nossaman BD.

J Cardiothorac Vasc Anesth. 2016 Aug;30(4):917-23. doi: 10.1053/j.jvca.2015.12.003. Epub 2015 Dec 3.

PMID:
27020101
10.

Role of Special Coagulation Studies for Preoperative Screening of Thrombotic Complications in Simultaneous Pancreas-Kidney Transplantation.

Moiz A, Javed T, Bohorquez H, Bruce DS, Carmody IC, Cohen AJ, Staffeld-Coit C, Luo Q, Loss GE Jr, Garces J.

Ochsner J. 2015 Fall;15(3):272-6. Erratum in: Ochsner J. 2016 Spring;16(1):5.

11.

"Weighing the risk": Obesity and outcomes following liver transplantation.

Reichman TW, Therapondos G, Serrano MS, Seal J, Evers-Meltzer R, Bohorquez H, Cohen A, Carmody I, Ahmed E, Bruce D, Loss GE.

World J Hepatol. 2015 Jun 18;7(11):1484-93. doi: 10.4254/wjh.v7.i11.1484. Review.

12.

Primary stent placement for hepatic artery stenosis after liver transplantation.

Le L, Terral W, Zea N, Bazan HA, Smith TA, Loss GE, Bluth E, Sternbergh WC 3rd.

J Vasc Surg. 2015 Sep;62(3):704-9. doi: 10.1016/j.jvs.2015.04.400. Epub 2015 Jun 6.

13.

Robotic-assisted laparoscopic donor nephrectomy: decreasing length of stay.

Cohen AJ, Williams DS, Bohorquez H, Bruce DS, Carmody IC, Reichman T, Loss GE Jr.

Ochsner J. 2015 Spring;15(1):19-24.

14.

Calciphylaxis in simultaneous liver-kidney transplantation.

Bohorquez HE, Chamorro N, Garces J, Cohen AJ, Reichman TW, Davis NK, Vincent B, Bruce DA, Carmody IC, Moiz A, Staffeld C, Loss GE.

Am J Transplant. 2015 Apr;15(4):1105-9. doi: 10.1111/ajt.13082. Epub 2015 Feb 25. No abstract available.

15.

Adverse cardiac events after orthotopic liver transplantation: a cross-sectional study in 389 consecutive patients.

Nicolau-Raducu R, Gitman M, Ganier D, Loss GE, Cohen AJ, Patel H, Girgrah N, Sekar K, Nossaman B.

Liver Transpl. 2015 Jan;21(1):13-21. doi: 10.1002/lt.23997.

16.

Phaeohyphomycosis fungal infections in solid organ transplant recipients: clinical presentation, pathology, and treatment.

Schieffelin JS, Garcia-Diaz JB, Loss GE Jr, Beckman EN, Keller RA, Staffeld-Coit C, Garces JC, Pankey GA.

Transpl Infect Dis. 2014 Apr;16(2):270-8. doi: 10.1111/tid.12197. Epub 2014 Mar 17.

PMID:
24628809
17.

Liver transplantation at the ochsner clinic: quality and outcomes improvement.

Therapondos G, Bohorquez H, Bruce DS, Bzowej NH, Carmody IC, Cohen AJ, Girgrah N, Joshi S, Reichman TW, Loss GE Jr.

Ochsner J. 2013 Fall;13(3):413-8. Review.

18.

Excellent liver retransplantation outcomes in hepatitis C-infected recipients.

Kressel A, Therapondos G, Bohorquez H, Borg B, Bruce D, Carmody I, Cohen A, Girgrah N, Joshi S, Reichman T, Loss GE.

Clin Transplant. 2013 Jul-Aug;27(4):E512-20. doi: 10.1111/ctr.12182. Epub 2013 Jul 16.

PMID:
23859312
19.

Tumor Necrosis Factor-α: Life and Death of Hepatocytes During Liver Ischemia/Reperfusion Injury.

Shuh M, Bohorquez H, Loss GE Jr, Cohen AJ.

Ochsner J. 2013 Spring;13(1):119-30.

20.

Liver transplantation in hepatitis B core-negative recipients using livers from hepatitis B core-positive donors: a 13-year experience.

Bohorquez HE, Cohen AJ, Girgrah N, Bruce DS, Carmody IC, Joshi S, Reichman TW, Therapondos G, Mason AL, Loss GE.

Liver Transpl. 2013 Jun;19(6):611-8. doi: 10.1002/lt.23644.

21.

Liver transplantation in a patient with Ehlers-Danlos syndrome.

Bohorquez HE, Gomez D, Cohen AJ, Bruce DS, Carmody IC, Reichman TW, Loss GE.

Liver Transpl. 2013 May;19(5):565-6. doi: 10.1002/lt.23627. Epub 2013 Apr 9. No abstract available.

22.

Endovascular treatment of hepatic artery stenosis after liver transplantation.

Hamby BA, Ramirez DE, Loss GE, Bazan HA, Smith TA, Bluth E, Sternbergh WC 3rd.

J Vasc Surg. 2013 Apr;57(4):1067-72. doi: 10.1016/j.jvs.2012.10.086. Epub 2013 Jan 18.

23.

Liver transplantation at the Ochsner Clinic: programmatic expansion and outcomes improvement.

Carmody IC, Reichman TW, Bohorquez H, Cohen AJ, Bruce DS, Therapondos G, Girgrah N, Joshi S, Loss GE.

Clin Transpl. 2012:111-20.

PMID:
23721014
24.

Improving Donor Livers by Inhibiting TNF-α Production.

Zetzmann CP, Swamy OR, Loss GE Jr, Bohorquez H, Cohen AJ.

Ochsner J. 2010 Winter;10(4):250-5.

25.

Reflections on a post-katrina transplant program.

Loss GE Jr.

Ochsner J. 2010 Winter;10(4):226. No abstract available.

PMID:
21603387
Free PMC Article
26.

Donor transmission of malignant melanoma to a liver graft recipient: case report and literature review.

Kim JK, Carmody IC, Cohen AJ, Loss GE.

Clin Transplant. 2009 Aug-Sep;23(4):571-4. doi: 10.1111/j.1399-0012.2008.00928.x. Review.

PMID:
19681978
27.
28.

Reduction of immunosuppression for transplant-associated skin cancer: expert consensus survey.

Otley CC, Berg D, Ulrich C, Stasko T, Murphy GM, Salasche SJ, Christenson LJ, Sengelmann R, Loss GE Jr, Garces J; REDUCTION OF IMMUNOSUPPRESSION TASK FORCE OF THE INTERNATIONAL TRANSPLANT SKIN CANCER COLLABORATIVE and THE SKIN CARE IN ORGAN TRANSPLANT PATIENTS EUROPE.

Br J Dermatol. 2006 Mar;154(3):395-400.

PMID:
16445766
29.

Early postoperative hepatic sonography as a predictor of vascular and biliary complications in adult orthotopic liver transplant patients.

Uzochukwu LN, Bluth EI, Smetherman DH, Troxclair LA, Loss GE Jr, Cohen A, Eason JD.

AJR Am J Roentgenol. 2005 Dec;185(6):1558-70.

PMID:
16304013
30.

Tolerance: is it worth the risk?

Eason JD, Cohen AJ, Nair S, Alcantera T, Loss GE.

Transplantation. 2005 May 15;79(9):1157-9.

PMID:
15880061
31.

Miller fisher variant of guillain-barre syndrome requiring a cardiac pacemaker in a patient on tacrolimus after liver transplantation.

Kaushik P, Cohen AJ, Zuckerman SJ, Vatsavai SR, Pepper JS, Banda VR, Eason JD, Loss GE Jr, Kaushik R.

Ann Pharmacother. 2005 Jun;39(6):1124-7. Epub 2005 Apr 26.

PMID:
15855240
32.

Does lamivudine prophylaxis eradicate persistent HBV DNA from allografts derived from anti-HBc-positive donors?

Loss GE Jr, Mason AL, Nair S, Blazek J, Farr G, Guo L, Cohen AJ, Eason JD.

Liver Transpl. 2003 Dec;9(12):1258-64.

33.

Steroid-free liver transplantation using rabbit antithymocyte globulin and early tacrolimus monotherapy.

Eason JD, Nair S, Cohen AJ, Blazek JL, Loss GE Jr.

Transplantation. 2003 Apr 27;75(8):1396-9.

PMID:
12717237
34.

Liver transplantation for hepatocellular carcinoma: the ochsner experience.

Loss GE Jr, Nair S, Blazek JL, Farr GH Jr, Eason JD.

Ochsner J. 2002 Fall;4(4):215-20.

35.

Innovative medical management with resection for successful treatment of pulmonary mucormycosis despite diagnostic delay.

MacKenzie KM, Baumgarten KL, Helm BM, McFadden PM, Deduska NJ, Loss GE Jr, Eason JD.

J La State Med Soc. 2002 Mar-Apr;154(2):82-5.

PMID:
12014459
36.

Transplantation of livers from hbc Ab positive donors into HBc Ab negative recipients: a strategy and preliminary results.

Loss GE, Mason AL, Blazek J, Dick D, Lipscomb J, Guo L, Perrillo RP, Eason JD.

Clin Transplant. 2001;15 Suppl 6:55-8.

PMID:
11903388
37.
38.

Transplant therapy for type 1 diabetes mellitus.

Loss GE, Grewal HP.

Ochsner J. 2001 Jul;3(3):144-8.

39.

Steroid-free immunosuppression through thymoglobulin induction in liver transplantation.

Eason JD, Blazek J, Mason A, Nair S, Loss GE.

Transplant Proc. 2001 Feb-Mar;33(1-2):1470-1. No abstract available.

PMID:
11267378
40.

Combined liver and kidney transplantation in children.

Grewal HP, Brady L, Cronin DC 2nd, Loss GE, Siegel CT, Oswald K, Fisher JS, Bruce DS, Aronson AJ, Woodle ES, Millis JM, Thistlethwaite JR, Newell KA.

Transplantation. 2000 Jul 15;70(1):100-5.

PMID:
10919582
41.

Complications in 100 living-liver donors.

Grewal HP, Thistlewaite JR Jr, Loss GE, Fisher JS, Cronin DC, Siegel CT, Newell KA, Bruce DS, Woodle ES, Brady L, Kelly S, Boone P, Oswald K, Millis JM.

Ann Surg. 1998 Aug;228(2):214-9.

42.

Tacrolimus/mycophenolate provides superior immunosuppression relative to neoral/mycophenolate in synchronous pancreas-kidney transplantation.

Bruce DS, Woodle ES, Newell KA, Millis JM, Cronin DC 2nd, Loss GE, Grewal HP, Siegel CT, Pellar S, Josephson MA, Thistlethwaite JR Jr.

Transplant Proc. 1998 Jun;30(4):1538-40. No abstract available.

PMID:
9636625
43.

Cyclosporine versus cyclosporine microemulsion in pediatric liver transplant recipients.

Loss GE Jr, Brady L, Grewal HP, Siegel CT, Mead J, Bruce DS, Cronin DC, Woodle ES, Newell KA, Thistlethwaite JR Jr, Millis JM.

Transplant Proc. 1998 Jun;30(4):1435-6. No abstract available.

PMID:
9636581
44.

Successful use of tacrolimus for initial rejection episodes after liver transplantation.

Millis JM, Cronin DC, Newell KA, Bruce DS, Woodle ES, Grewal HP, Loss GE, Lissoos T, Conjeevaram H, Schiano T, O'Laughlin R, Charette J, McNaughton M, Baker AL, Thistlethwaite JR Jr.

Transplant Proc. 1998 Jun;30(4):1407-8. No abstract available.

PMID:
9636569
45.

Corticosteroid cessation 1 week following renal transplantation using tacrolimus/mycophenolate mofetil based immunosuppression.

Grewal HP, Thistlethwaite JR Jr, Loss GE, Bruce DS, Siegel CT, Cronin DC, Newell KA, Millis JM, Woodle ES.

Transplant Proc. 1998 Jun;30(4):1378-9. No abstract available.

PMID:
9636558
46.

Reversal of delayed hyperacute renal allograft rejection with a tacrolimus-based therapeutic regimen.

Loss GE Jr, Grewal HP, Siegel CT, Peace D, Mead J, Bruce DS, Cronin DC, Millis JM, Newell KA, Woodle ES.

Transplant Proc. 1998 Jun;30(4):1249-50. No abstract available.

PMID:
9636508
47.

Tacrolimus therapy for refractory acute renal allograft rejection: a 4-year experience with an aggressive approach.

Turner CD, Bruce DS, Cronin DC, Loss GE, Grewal H, Siegel C, Millis JM, Newell KA, Davis B, Todo T, Thistlethwaite JR, Woodle ES.

Transplant Proc. 1998 Jun;30(4):1234-5. No abstract available.

PMID:
9636501
48.

Effects of tacrolimus, mycophenolate mofetil, and cyclosporine microemulsion on rejection incidence in synchronous pancreas-kidney transplantation.

Bruce DS, Woodle ES, Newell KA, Millis JM, Cronin DC 2nd, Loss GE, Pellar S, Josephson MA, Thistlethwaite JR Jr.

Transplant Proc. 1998 Mar;30(2):507-8. No abstract available.

PMID:
9532150
49.

Incidence and outcome of infection by vancomycin-resistant Enterococcus following orthotopic liver transplantation.

Newell KA, Millis JM, Arnow PM, Bruce DS, Woodle ES, Cronin DC, Loss GE, Grewal H, Lissoos T, Schiano T, Mead J, Thistlethwaite JR Jr.

Transplantation. 1998 Feb 15;65(3):439-42.

PMID:
9484768
50.

The requirement for DM in class II-restricted antigen presentation and SDS-stable dimer formation is allele and species dependent.

Stebbins CC, Loss GE Jr, Elias CG, Chervonsky A, Sant AJ.

J Exp Med. 1995 Jan 1;181(1):223-34.

Supplemental Content

Support Center